Avanir Pharmaceuticals, Azur Pharma sales and marketing update

AVNR will sell worldwide rights to schizophrenic treatment FazaClo clozapine to Azur. AVNR will receive $42 million up front and is eligible for $10 million in milestones, plus up to $2 million in ro...